Drug Safety and Availability > CDER Statement: FDA alerts pharmacies to concerns with testing conducted by Front Range Laboratories:
"In a recent inspection, FDA investigators observed that methods used by Front Range to assess sterility and other qualities (e.g., strength and stability) may have resulted in pharmacies receiving inaccurate laboratory test results. FDA has concerns that results obtained from Front Range are not reliable. FDA recommends that pharmacies not use this firm for sterility and other quality attributes testing at this time."
Return Home: The Designated Representative and Exemptee Blog
CA Designated Representative online web-based training certification by SkillsPlus Intl Inc.
FL Designated Representative online e-Learning exam preparation by SkillsPlus Intl Inc.
The Designated Representative Institute
CA HMDR Exemptee online internet-based training certification by SkillsPlus Intl Inc.
The Exemptee Institute
SkillsPlus Intl Info Blog
Reimbursement Cuts to NY Medicaid Incontinence Supplies
24 minutes ago